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Abstract
Vertebrate studies show neuroligins and neurexins are binding partners in a trans-synaptic cell adhesion complex,
implicated in human autism and mental retardation disorders. Here we report a genetic analysis of homologous proteins in
the honey bee. As in humans, the honeybee has five large (31–246 kb, up to 12 exons each) neuroligin genes, three of which
are tightly clustered. RNA analysis of the neuroligin-3 gene reveals five alternatively spliced transcripts, generated through
alternative use of exons encoding the cholinesterase-like domain. Whereas vertebrates have three neurexins the bee has just
one gene named neurexin I (400 kb, 28 exons). However alternative isoforms of bee neurexin I are generated by differential
use of 12 splice sites, mostly located in regions encoding LNS subdomains. Some of the splice variants of bee neurexin I
resemble the vertebrate a- and b-neurexins, albeit in vertebrates these forms are generated by alternative promoters. Novel
splicing variations in the 39 region generate transcripts encoding alternative trans-membrane and PDZ domains. Another 39
splicing variation predicts soluble neurexin I isoforms. Neurexin I and neuroligin expression was found in brain tissue, with
expression present throughout development, and in most cases significantly up-regulated in adults. Transcripts of neurexin I
and one neuroligin tested were abundant in mushroom bodies, a higher order processing centre in the bee brain. We show
neuroligins and neurexins comprise a highly conserved molecular system with likely similar functional roles in insects as
vertebrates, and with scope in the honeybee to generate substantial functional diversity through alternative splicing. Our
study provides important prerequisite data for using the bee as a model for vertebrate synaptic development.
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Introduction
Vertebrate neuroligins and neurexins are trans-membrane cell
adhesion molecules found predominantly on the post- and pre-
synaptic membrane of synapses, respectively [1,2]. Together they
form an adhesion complex, which bridges the post- and pre-
synaptic compartments of a synapse, thereby facilitating the
development, specification and maintenance of a mature synapse.
Neuroligin genes have been identified in all animal genomes
characterised but have been most thoroughly analysed in humans,
mouse and rat [3,4]. Three neuroligin genes are found in the
rodents, and five in the human genome. Automated annotation of
sequenced invertebrate genomes has identified neuroligins in the
fruit fly (Drosophila melanogaster), mosquito (Anopheles gambiae),
nematode worm (Caenorhabditis elegans) and honeybee (Apis mellifera)
[5,6]. Neuroligins are type I trans-membrane proteins comprised
of a cleavable signal peptide, a large extracellular cholinesterase-
like domain, EF-hand metal binding motifs, a short (O-linked)
carbohydrate binding region linked to a single trans-membrane
domain and a short cytosolic tail containing a PDZ (Postsynaptic
density 95/Discs large/Zona occludens 1) binding motif [7]. The
extracellular cholinesterase-like domain of neuroligins participates
in binding with neurexin. This domain possesses an a/b-hydrolase
fold structure characteristic of the carboxyl-cholinesterase super-
family [8–10]. Although they lack the key active site residues
required for catalytic competence as an esterase, the neuroligins
are in fact the closest structural relative of the critical neurological
enzyme acetylcholinesterase (AChE; [10]). Their amino acid
sequence identity is low (,30%) and the two proteins appear to
have diverged before the divergence of the metazoa and porifera
(C.Claudianos unpublished), but none-the-less some functional
redundancy exists. Non-catalytic roles for AChE have been well
established [11,12], including a redundant neuritogenesis capacity
shared with the neuroligins whereby both are able to affect
neurexin expression [13,14].
Alternative splicing of the vertebrate neuroligins arises from
differential use of sites localised within the cholinesterase-like
domain. A single site of alternative splicing (splice site A) has been
found in human neuroligins-1, -2 and -3, with an additional site
(splice site B) also found in neuroligin-1 [15]. However alternative
splicing has not yet been reported for human neuroligins -4X and -
4Y or any invertebrate neuroligins. Alternative splicing of the
vertebrate neuroligins is critical to neuroligin-neurexin biology, in
part determining whether an interaction occurs with either a-
neurexin or b-neurexin [7,16].
Neurexin genes have also been identified in all vertebrate and
invertebrate genomes sequenced thus far. The well characterised
mammalian systems all have three neurexin genes, each with both
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promoter generates a larger protein called a-neurexin, whilst the
downstream promoter gives rise to a smaller product called b-
neurexin. The a- and b-neurexins are both single-pass trans-
membrane proteins comprising a signal peptide, extracellular
domain, trans-membrane domain, carbohydrate region and
cytoplasmic tail [18]. The a-neurexins have a large extracellular
domain made up of three repeats: each made up of two LNS
(Laminin, Neurexin, Sex hormone-binding globulin) motifs
flanking an EGF (Epidermal Growth Factor) motif. The b-
neurexins have a single LNS motif and a unique N terminal
stretch. In addition to the use of alternative promoters, vertebrate
neurexin transcripts gain diversity through alternative splicing
within exons encoding their extracellular domains. Vertebrate a-
neurexins possess five alternative splice sites, two of which are also
found in b-neurexins [19,20]. Similar to alternative splicing in the
neuroligins, alternative splicing of the neurexins controls binding
between the neuroligins and neurexins [7,16]. Alternative splicing
has not yet been reported for any invertebrate neurexins [20].
Vertebrate studies show that both neuroligins and neurexins
participate in bi-directional protein-protein interactions at the
synapse. Their N-terminal regions interact with one another in the
extracellular synaptic compartment [21]; and binding of calcium
to the neurexin is necessary for this interaction to occur [15,52].
They also both interact with a number of intracellular PDZ motif-
containing partners via their C-termini. The PDZ-motif partners
behave as scaffolding molecules which in turn interact with
transmitter receptors, ion channels and signalling proteins [22–
27]. The first direct evidence implicating the neuroligin-neurexin
complex in synapse formation came from studies which used
cultured neurons to illustrate that neuroligins can promote the
development of functional presynaptic terminals by binding with
neurexin [28]. Further mammalian work then illustrated the
capacity of neurexin to induce the assembly of postsynaptic
proteins in cultured cells [29,30]. This has since been demon-
strated in Drosophila, by in vivo neurexin I over-expression [31].
Increased synapse formation was observed when verterbrate
neuroligin was over-expressed in cultured neurons [29,30,32–35]
and, conversely, reduced synapse density and changes in synapse
activity were found by RNAi knock down of neuroligin expression
[32]. Intriguingly, knock-out studies of neuroligins (single, double
and triple knock-outs) or neurexin in mice show no changes to the
density of synaptic contacts [36,37]. However the neuroligin
knockouts, similar to Drosophila neurexin I loss of function mutants
[31], show reduced synaptic transmission and network activity in
the brainstem. Arguably neuroligins do not play a role in the initial
formation of synaptic contacts in vivo, but instead are involved in
directing synapse maturation.
Several lines of evidence now suggest that the complex affects
synapse specificity through differential effects on inhibitory versus
excitatory synapse development, and thus on the excitatory/
inhibitory (E/I) synapse ratio in the brain [29,32,35,38] These
findings include evidence for clustering with downstream signal-
ling and scaffolding molecules, such as gephyrin, and show
differences amongst neuroligin isoforms in their influence on
excitatory and inhibitory synapse function. This complements
research implicating human neuroligins and neurexins in neuro-
developmental psychiatric disorders where an imbalance in E/I
ratio is thought to occur. Numerous studies have localised
mutations to neuroligin 3 and 4 in families affected by autism,
Aspergers syndrome and X-linked mental retardation [39–42].
The disease mutations in neuroligin 3 and 4 lead to loss of neurexin
binding, loss of synaptogenic capability and retention in the
endoplasmic reticulum [43,44]. Recent studies have also identified
a high frequency of neurexin structural variants in families affected
with autism and schizophrenia [45,46].
The aim of the current study is to establish the honey bee as an
invertebrate model for investigating the neurobiology of the
neuroligin/neurexin complex. The bee is a neurologically
sophisticated organism with well understood social biology-
offering an avenue for effective learning and memory assays. In
particular this study characterises the genetics of the neuroligins
and neurexins in the bee. We find five neuroligin genes in the bee, as
in humans, but only one neurexin gene, with a single promoter.
However, functional diversity is achieved by much higher levels of
alternative splicing in the exons encoding the extracellular
domains of both neuroligin and neurexin genes in the bee. The bee
genes are heavily but differentially expressed during development
and concentrated in the mushroom bodies, which is the higher
order processing centre of the bee brain.
Results
Neuroligin genes, gene structure and orthologs
We conducted in silico homology based searches of the honeybee
genome [47] using predicted fruit fly (Drosophila melanogaster) and
mosquito (Anopheles gambiae) neuroligin sequences [48]. The searches
confirmed five Beebase Glean-3 annotations, GB18720, GB10066,
GB18290, GB18836 and GB13939, as putative neuroligin sequences
[49] (‘BeeBase’ http://racerx00.tamu.edu/). Specific nucleotide
primers were then used to PCR amplify five neuroligin cDNAs from
reverse-transcribed adult honeybee brain RNA. These are named
AmNLG1-5 according to their presumptive orthologies with other
invertebrate neuroligins (Figure 1.1). Sequence analysis from the
cloned amplicons showed that AmNLG -1,- 3,- 4 and -5 were full
length cDNAs, each about approximately 2.5 kb in length. Despite
strong sequence conservation between predicted orthologs and
various attempts using different primer and PCR conditions, we
were unable to verify the 59 coding regions of AmNLG2. This may
be due in part to significant secondary structure in the mRNA
transcript as a consequence of the high GC rich content at the 59-
end of the AmNLG2 gene. Verified coding sequence, including
1645 bp of the 39 portion of AmNLG2, is given in Figure S1 of the
Supplementary Data.
BLAST analyses of the complete honeybee genome identified
the chromosomal locations of the five newly cloned neuroligins. Four
of five neuroligins are located on chromosome 9, whereas AmNLG2 is
located on chromosome 1 (Table 1). Comparison between physical
maps of neuroligins from the honeybee, fly and mosquito shows that
NLG -1,-3 and -4 form a tightly linked cluster of genes, with the
same order and orientation of orthologs in all three genomes [49].
Considering that dipteran and hymenopteran insects diverged
over 300 million years ago, the conservation of this microsynteny
may reflect a selective constraint.
The phylogenetic relationships of the inferred amino acid
sequences of the honeybee, fly, beetle and nematode neuroligin
sequences show these as clear 1:1 orthologs (Figure 1.1). Although
there are no obvious orthologs between vertebrates and insects, all
the invertebrate molecules including a single C. elegans (nematode
worm) neuroligin share a common ancestry with the vertebrate
neuroligins via a single basal ortholog, the sea urchin neuroligin
(Figure 1.1). Interestingly, what would seem to be distinct
vertebrate and invertebrate gene radiations separated by hundreds
of millions of years of evolution result in an equivalent number of
neuroligins (five) occurring in both humans and honeybees. Five
putative neuroligin sequences are also found in the mosquito
genome, orthologs of the five honeybee neuroligins [49]. Drosophila
however, has only four neuroligins and lacks an ortholog of
Insect Neurexin and Neuroligin
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members of gene families that are otherwise conserved between
other invertebrate genomes [47].
Genomic scaffolds (obtained from BeeBase) were analysed using
SPIDEY (NCBI) to determine intron/exon arrangements of the
honeybee neuroligins (Table 1). Canonical intron donor and
acceptor splice site configurations (that typically contain GT/
AG) were found to border the exon boundaries predicted from the
homology searches and cDNA data. The numbers of exons and
introns identified in the five genes were quite similar, around 8–12
each, with conservation of 8 intron/exon splice site junctions
found between two or more of the honeybee neuroligins. All five
genes have at least 10 fold more intron than exon sequence but the
sizes of some introns varies widely between genes so that total gene
length ranges from 31.2 kb (AmNLG5) to 246 kb (AmNLG3).
An alignment of predicted neuroligin proteins from the honeybee,
fly,nematodeandhumanindicatessignificantintron/exonsplicesite
conservation among orthologs (the mosquito neuroligin sequences
were not included in this analysis due to several incomplete gene
predictions); for example, eight out of nine intron/exon splicesites in
AmNLG3 are conserved in the Drosophila ortholog CG34127 (Figure
S2). Splice site conservation amongst the honeybee neuroligin
paralogs is lower than between orthologs in other species, but still
discernable.Thegreaterclosenessbetweenneuroliginorthologsthan
paralogs is also seen at the level of amino acid sequence identity; for
example there is 27–48% amino acid identity between the honeybee
paralogs compared with 59% identity between honeybee and
Drosophila NLG3. Across the five honeybee neuroligins, there are 7–
11 intron/exon splice junctions. Importantly, all five honeybee
neuroligins possess the four intron/exon splicejunctionsfound inthe
human neuroligins (Figure S2), and share an overall 24–32% amino
acid identity with the five human sequences. These results suggest
that a series of gene duplication events gave rise to the extant set of
proteins and that their organisation has been substantively
constrained over 800 million years of subsequent evolution.
Neuroligin Proteins
Structural motifs characteristic of vertebrate neuroligins are
generally present in the honeybee molecules; namely, a signal
peptide, cholinesterase-like domain, EF-hand metal binding motifs
Figure 1. Neuroligin and Neurexin Phylogeny. (1.1) shows the
phylogenetic relationship of 53 neuroligin proteins from the honeybee
(AmNLG1-5) and Drosophila fly together with other neuroligins
described by Bolliger et al [105]. All sequences are represented by
taxon names showing species and NCBI accession numbers. The
evolutionary history was inferred using the Neighbor-Joining method
[106]. An optimal tree with percentage of replicate trees in which the
associated taxa clustered together in the bootstrap test (1000
replicates) is shown next to the branches [107]. The tree is drawn to
scale, with branch lengths in the same units as those of the
evolutionary distances used to infer the phylogenetic tree. The
evolutionary distances were computed using the JTT matrix based
method [108] and are in the units of the number of amino acid
substitutions per site. All positions containing alignment gaps and
missing data were eliminated only in pairwise sequence comparisons
(Pairwise deletion option). There were a total of 1884 positions in the
final dataset. Phylogenetic analyses were conducted in MEGA3.1 [94].
Four radiations (shaded) represent relationship of vertebrate proteins
NLG1-4 compared with invertebrate proteins. The phylogeny shows
vertebrate and invertebrate neuroligin radiations arise from a single
common ancestor found in the sea urchin (S. purpuratus
XP_001192426), and displays a congruent topology with the Max-
imum-Likelihood tree reported by Bolliger et al. [105]. Similar analysis
was performed for investigating neurexin phylogeny. (1.2) shows the
evolutionary relationship of two ancestrally related clades of neurexin
proteins from vertebrates and invertebrates; the neurological neurexins
(NrxI) and neurexin IV (also known as neurexin). Notably, the
invertebrate neurexin IV proteins form an orthologous group with
CASPR. There were a total of 2125 positions in the final dataset. Also
shown are the NCBI and wormbase accession numbers. Abbreviations
Am: Apis mellifera, honeybee.
doi:10.1371/journal.pone.0003542.g001
Table 1. Neuroligins and Neurexin I in the Honeybee.
Gene Chromosome
Size of
gene
*Size of mature
transcript Exon Number
Am NLG1 9 55.8 kb 2430 bp 12
Am NLG2 1 45.9 kb 2550 bp 8
Am NLG3 9 246 kb 2424 bp 11
Am NLG4 9 215 kb 2433 bp 10
Am NLG5 9 31.2 kb 2553 bp 9
AmNrxI_A 5 391 kb 4872 bp 27
AmNrxI_B 5 394 kb 3633 bp 23
*Size of mature transcript refers to length of the open reading frame cDNA
(exons only) from start to stop codon, without introns.
doi:10.1371/journal.pone.0003542.t001
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valine C-terminal residues essential for the function of the PDZ
(Postsynaptic density 95/Discs large/Zona occludens 1) binding
domain [22] are also present in all of the five honeybee
neuroligins, suggesting that the intracellular protein-protein
interactions may also be similar to their vertebrate counterparts.
Glycosylation in neuroligins has been shown to be physiolog-
ically important; specifically, N-linked glycosylation of vertebrate
neuroligin 1 has been demonstrated to inhibit b-neurexin binding
[7,10]. Of the four sites of N-linked glycosylation that have been
characterised in human neuroligins, namely N109, N303, N343
and N547 [10], only N547 is conserved in the honeybee and other
invertebrate neuroligins. It may therefore be N547 which under-
goes glycosylation in the invertebrate molecules as a method of
regulating neurexin-neuroligin binding (Figure S2). O-linked
glycosylation has also been shown to affect human neuroligin
function. The two O-linked glycosylation sites (S683 and S686) are
found in a proline-rich bottle brush-like structure that forms a
‘linker region’ between the esterase and trans-membrane domains
[10], and is known to participate in neuroligin oligomerisation and
mediate synaptogenic activity and neurexin binding [33]. The
honeybee and Drosophila neuroligin 1 sequences possess equivalent
O-linked glycosylation sites, and several additional serine and
threonine residues are also present in this region (Figure S2). Thus
O-linked glycosylation and oligomerisation of invertebrate neuro-
ligins may follow the vertebrate model.
The recent publication of three crystal structures of human (H.
sapiens) and mouse (M. musculus) neuroligin-neurexin complexes
[50–52] allowed us to construct homology models of Apis mellifera
NLG1 and NLG3 in order to analyse the sequence similarities and
differences between the respective carboxyl/cholinesterase do-
mains in greater detail. Although the mouse and human crystal
structures are essentially identical in terms of sequence, the mouse
structure was chosen as a template because of the marginally
higher sequence conservation with the bee sequence (37% cf. 36%
in respect to AmNLG3 for example). The alignments used to
construct the models (Figures S6 and S7) illustrate that, with the
exception of two 16 and 9 amino acid insertions in the AmNLG3
sequence, the proteins align closely.
Since cysteine residues play a critical role in defining the
structure of the carboxyl/cholinesterase family members and they
are highly conserved in vertebrate neuroligins [10,53–55],
potential disulfide bonds in the bee neuroligins were investigated
through sequence alignment analysis and, specifically for
AmNLG3, through the homology modelling analysis. The first
two disulfide bridges appear to be conserved (C117-C153, C342,
C353), while the third disulfide bridge (C512-C546) is absent,
despite relatively high sequence identity in the nearby secondary
structure elements. The loss of this inter-loop disulfide bridge
suggests the conformation of this region in AmNLG-1 and -3
could be significantly different to that of human and mouse NLG1;
interestingly, this disulfide bridge is located between the two
helices (450–460;620–635) that constitute the dimerization domain
in human and mouse neuroligins. A fourth disulfide bridge, found
within a region of the vertebrate neuroligins that undergoes
alternatively splicing [10] is also absent in the AmNLG3 sequence
(Figure S7).
As shown in Figures 2.1a and b, sequence conservation is very
strong in the interior of the protein, with the majority of the
sequence variation occurring on its surface. In fact, there is 52%
sequence identity between solvent-buried regions of the proteins
compared to only 19% sequence identity in solvent-exposed
regions. This result is consistent with the action of selective
pressure to maintain the structural integrity of the a/b hydrolase
fold, whereas there is apparently little selective pressure to retain
similar sequences at the protein surface [56]. We are particularly
interested in sequence conservation in functionally important areas
of the neuroligin protein surface, such as the dimerization interface
and the neuroligin/neurexin interface (discussed below). The
recent elucidation of these interfaces in the mammalian proteins,
initially revealed by low resolution X-ray scattering experiments
[21] and followed by high resolution crystal structures [50–52],
allowed us to identify the corresponding regions in our homology
model.
Neuroligin dimerization in the human and mouse structures
results from the withdrawal from solvent of an extensive
hydrophobic region comprised from two a-helices from each
monomer (a-12; 450–460, and a-18; 620–635). This symmetrical
hydrophobic ‘core’ is principally formed by W626, L625 and L629
forming the top and bottom regions, with W463 and F459 forming
the left and right sides, and a symmetrical M459-M459 interaction
at the centre, which has been observed in the dimerization of other
proteins [57]. The sequences of AmNLG1 and AmNLG3 are
surprisingly different in this region (Figure 2.2). AmNLG1 retains
the W626 and the hydrophobic character of L625(F) and W463(F),
but the three central residues are either polar or charged (H629,
E458, Q459). The conservation of hydrophobic residues at
positions 625 and 626 would be necessary for correct intramolec-
ular packing and folding of each monomer, but the increased
charge of the residues at the other positions is likely to significantly
affect inter-chain dimerization. Although it may be possible for
these residues to arrange such that the dimer interface will be
mediated by several hydrogen bonds, it is equally likely that these
differences would prevent dimerization in an analogous fashion to
the vertebrate structures. The corresponding regions of AmNLG3
also show differences that could compromise effective dimerisa-
tion. While the hydrophobic character at W626, L625 and W463
is again conserved, the central methionine is replaced by a
glutamic acid, making it highly unlikely the two acidic side chains
could pack closely together. However, given that the closely
related acetylcholinesterases have been characterised in mono-
meric, dimeric and tetrameric forms [58], there is some precedent
to suggest the possibility of differing molecular arrangements for
the inverterbrate neuroligins. Furthermore, although it seems the
dimerization contacts in human and mouse neuroligin are not
conserved in AmNLG1 and 3, because of the other amino acid
differences, including insertions and deletions, it is possible that an
alternative dimerization mechanism may exist. The oligomeric
state of the invertebrate enzymes and the molecular basis of their
interactions thus remain to be experimentally verified.
Mutations to neuroligin genes have recently been linked to
various neurological disorders. Mutations in human NL3 (R415C)
and NL4 (D396Stop, G99S, K378R, V403M and R704C) have
been identified in families affected by both mental retardation and
autism [39–42]. With the exception of R704C, all of these
mutations are associated with the carboxyl-cholinesterase domain
of the neuroligins [42]. The D396 and R415C mutations are
known to result in the retention of neuroligins in the endoplasmic
reticulum, preventing expression of neuroligin at the postsynaptic
membrane [43,44]. Crystallographic analysis revealed that most of
these mutations are in buried regions of the proteins, which
supports the observation that they have detrimental effects on the
structural integrity and folding of the protein [50–52]. Intriguing-
ly, a number of these polymorphisms naturally occur within
invertebrate neuroligins. For instance, the K278R and V403M
changes are found in DmNLG1 and 3 (CG31146, CG34139) and
the R415C change is found in AmNLG2 (Table 2; Figure S2).
This suggests that the effects of these mutations could be more
Insect Neurexin and Neuroligin
PLoS ONE | www.plosone.org 4 October 2008 | Volume 3 | Issue 10 | e3542Figure 2.Structural Homology Modelling. (2.1) shows neuroligin and neurexin I homology models. The similarity between MmNLG1 and (a) AmNLG1
and (b) AmNLG3 is illustrated using colour, where sequence similarity in blue represents identical; green represents conservative; yellow represents semi-
conservative and red represents dissimilar. Similarity to Mm b-Nrx1B with AmNrxI_A is illustrated using the same coloured coding. (2.2) shows the putative
honeybee neuroligin dimer interfaces. The neuroligin dimer interface from (a) the crystal structure of mouse neuroligin is shown alongside the putative
interfaces in (b) AmNLG1 and (c) AmNLG3. In both honeybee sequences the key residues of the ‘hydrophobic core’ are replaced by charged or polar
residues. (2.3) illustrates the homology modelling of AmNLG3 aternative slice vriants. The four spliced variants (b–e) of AmNLG3 are shown. Full length
AmNLG3 was modelled against mouse NLG1 [73]. Regions missing from the alternative transcripts are highlighted in red. (2.4) shows conservation of the
neuroligin-neurexin interface in the honeybee. Therespective surfaces of the neuroligin-neurexin interface are shown, based on the crystal structure of the
complex from mouse. Sequence similarity is shown (blue, identical; green, conservative; yellow, semi-conservative; red, dissimilar) illustrating, (a) the strong
conservation in AmNrxI-A, (b) the moderate conservation in AmNLG1, and (c) the lack of conservation in AmNLG3. (d) Illustrates a potential interaction
between AmNrx1-A and AmNLG1, showing the conserved salt bridges (R232-D387), hydrogen bonds (N103-D402), and the potentially complementary
hydrophobic and hydrophilic regions at the centre of the interface. Amino acids are coloured by type (blue, basic; red, acidic; yellow, polar; grey, non-polar).
doi:10.1371/journal.pone.0003542.g002
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required for the specific functions of insect neuroligins. The wild
type invertebrate neuroligins may therefore represent an interest-
ing model that could be applied to the study of these autism-linked
polymorphisms.
Neuroligin alternative splicing
Due to relatively high AmNLG3 expression throughout devel-
opment (discussed below), AmNLG3 was chosen as a candidate to
investigate alternative splicing. Candidate splice variants were
amplified using RT-PCR and primers corresponding to the start
and stop codons of the full-length gene (Table S1). Five
alternatively spliced transcripts of AmNLG3 were identified,
including the full length transcript (Figure 3). These are denoted
in decreasing order of transcript size AmNLG3, AmNLG3b,
AmNLG3c, AmNLG3d and AmNLG3e. There are three splice sites
which give rise to the five AmNLG3 alternatively spliced transcripts.
These coincide with the intron/exon splice junctions between
exons 1–2, 2–3, and 6–7 (Figure S3). Comparison between the
cDNA transcript sequence and corresponding genomic sequence
revealed that all of the intron/exon boundaries of the five
alternatively spliced transcripts are flanked by canonical AG/GT
donor and acceptor splice sites [59]. In addition to amplification
from expressed RNA, this relationship supports the conclusion
that the amplicons represent truly expressed transcripts.
The region encoded between exons 2 and 7, in which all
alternative splice sites of AmNLG3 are located, encodes the
adhesive carboxyl/cholinesterase domain (Figure 3.2, S3). All five
AmNLG3 isoforms retain the signal peptide sequence, trans-
membrane domain and intracellular cytosolic domain, suggesting
all isoforms have the capacity to interact with the same
intracellular postsynaptic proteins (Figure 3.2, S3). Importantly,
the critical C-terminal ‘RV’ amino acids involved in PDZ binding
are found in all five isoforms (Figure 3.2, S3).
There are two documented alternative splice sites in vertebrate
neuroligins, the first of which is shared by neuroligins 1, 2 and 3 (site
A), while the second (site B) is only found in neuroligin 1 [55]. There
is no alternative splicing attributed to humn neuroligins 4X and 4Y.
Comparison between the human neuroligins and the AmNLG3
variants shows that the first alternative splice site (A) of the human
neuroligins is conserved in AmNLG3 (Figure S3) and the second
splice site (B) in human NLG1 maps precisely to the intron/exon
3–4 splice junction in AmNLG3. Because there is a possibility that
some RNA transcripts were not detected in the tissue or life stage
from which the five cloned AmNLG3 transcripts arose, it is
conceivable that the second alternative splice in human neuroligin 1
may also be a site of alternative splicing in the honeybee.
The most striking difference between the honeybee and
vertebrate splice variants is the extent of the splicing: relatively
short stretches of sequence(s) (9–19 amino acids) are spliced out of
the vertebrate variants [55], whereas honeybee neuroligin 3 shows
whole exon splicing. The loss of exons 6 and/or exon 7 seen in
AmNLG3e, for example, would result in the loss of the majority of
the EF-hand metal binding motifs (Figure 3.2). The functional
consequence of this loss is unclear given vertebrate studies have
recently discovered that it is not neuroligin which binds calcium
(via this motif), but neurexin [50–52]. The extent of the splicing is
so extensive in AmNLG3e (9 of 11 b-strands of the central a-sheet
are missing), that it is doubtful whether AmNLG3e, if folded,
could assume an a/b hydrolase fold conformation. The splicing is
also extensive in the other three splice variants. AmNLG3c and
AmNLG3d lack one or two central b-strands (b-9 or b-9 and 10,
respectively) in addition to several structurally important a-helices.
AmNLG3b uniquely lacks b-9 in addition to two surrounding
helices and the loop that in human and mouse neuroligins contacts
b-neurexin 1 (Figure 2.3).
From a structural viewpoint, it is difficult to imagine how these
splicing variants could correctly fold to give rise to soluble protein.
There are, however, some observations that suggest these
alterative transcripts may produce soluble protein. Firstly, all of
the splice sites are within the carboxyl/cholinesterase domain.
Secondly, the a/b-hydrolase fold that this domain adopts is
notoriously flexible with respect to accommodating extensive
alternative splicing, insertions and deletions, and still giving rise to
viable protein [56]. Indeed, other instances of alternative splicing
that produce viable protein resulting from the excision of entire
domains have been reported, such as the vasopressin receptor
[61]. Thus, in the absence of further empirical work, it remains
possible that these isoforms are expressed and functionally
relevant.
From another perspective, shorter alternatively spliced tran-
scripts of other genes have been known to behave as a regulatory
mechanism influencing the translation of their respective full
length variants [60,61]. AmNLG3 splicing may therefore be
behaving in a similar way. In fact, genome wide analysis of the
honeybee genome has identified a micro RNA in association with
AmNLG2 [62]. Given micro RNAs are non-coding RNA molecules
which can behave as potential regulators of gene expression at the
post-transcriptional level, there is precedent to suggest that the
various honeybee neuroligins (and thus specific variants) may be
subject to differential degradation post-transcription.
Alternatively spliced transcripts of human neuroligins 3 and 4X
were recently found to be unique to individuals affected by autism
[63]. Intriguingly, the disease-associated splicing patterns give rise
to transcripts that mimic alternatively spliced transcripts in the
Table 2. Neuroligin (NLG) Disease-Associated Polymorphisms.
Gene
Disease
Mutation
K378R
Disease
Mutation
V403M
Disease
Mutation
R415C
Hm NLG1 K V R
Hm NLG2 K V R
Hm NLG3 K V R
Disease Hm NLG3* (Jamain et al.
2003)
C*
Hm NLG4X K V R
Diesase Hm NLG4X* (Laumonnier
et al. 2004)
R* M*
Hm NLG4Y K V R
Am NLG1 L A R
Am NLG2 N V C
Am NLG3 A V K
Am NLG4 K V R
Am NLG5 G I R
Dm NLG1 (CG31146) T M* R
Dm NLG2 (CG13772) D V R
Dm NLG3 (CG34127) S V R
Dm NLG4 (CG34139) R* V R
Ce NLG M V R
*Hm=human; Am=Apis mellifera;D m=Drosophila melangaster;
Ce=Caenorhabditis elegans; asterirsk=gene/citation/mutation found through
familial disease data.
doi:10.1371/journal.pone.0003542.t002
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individuals are typically missing exon 2 of the open reading frame,
which is an identical splicing pattern to that which gives rise to
AmNLG3c (Figure S3). Likewise, splicing of neuroligin 3 in autistic
individuals results in the loss of exon 5 from the open reading
frame, which aligns with exons 4 to 8 of AmNLG3, inclusively
(Figures S2, S3). Although splicing of exon 8 has not been
identified in the honeybee, exons 4, 5, 6 and 7 are alternatively
spliced in varying combinations in AmNLG3b, AmNLG3d and
AmNLG3e. Talebizadeh et al. [63] hypothesized that the disease-
associated human isoforms could play a regulatory role by
attenuating the function of the full-length isoform. The functional
consequence of this may affect the balance between excitatory and
inhibitory synapse development, similar to the regulatory mech-
anism of the vasopressin receptor protein [63,64]. AmNLG3
alternate isoforms, therefore, may also play a role in regulating the
function of the full-length molecule in the honeybee, albeit this
would be part of the bee’s normal biology.
Neurexin I gene, gene structure and orthologs
Homology-based searches of the honeybee genome were
performed using the putative Drosophila neurexin sequences
CG7050 [65] and CG6827. Two honeybee neurexin sequences
corresponding to Glean3 Beebase predictions GB18754 and
GB14382 were identified. GB14382 proved to be the ortholog
of the vertebrate CASPR gene, a non-neurological gene distantly
related to the neurexins and not associated with neuroligin biology
(see Figure 1.1). Therefore, GB14382 was not characterized
further. However, the sequence of GB18754 showed a close match
to Drosophila Neurexin 1 (DmNrx1; CG7050) [65], except at the 39
ends adjoining the stop codon. Specifically, the GB18754 sequence
predicted a stop codon approximately 2.5 kb downstream of the
stop codon found by homology based searching with CG7050.
To reconcile the alternative stop codons in the honeybee gene,
two separate RT-PCR reactions were performed. Both used a
common forward primer designed to the ATG start codon, but
used different reverse primers designed to the two putative
Figure 3. Honeybee Neuroligin 3 Gene Arrangement and Intron/Exon Conservation. AmNLG3 alternatively spliced transcripts were
identified by RT-PCR from honeybee brain cDNA. Arrangement and intron/exon splice sites of AmNLG3 splice variants were deciphered by both NCBI
and Beebase BLAST tools against genomic DNA. Donor/acceptor splice sites were confirmed using NCBI SPIDEY. Sizes of exons, as well as intron gaps,
are not drawn to scale. Exons are numbered from 59 to 39. (a) highlights the three sites of alternative splicing and resulting splice patterns. (b)
illustrates the five alternatively spliced AmNLG3 transcripts which correspond to the splicing patterns show in (a). The bracket highlights that splicing
occurs within the cholinesterase domain. Signal peptide, cholinesterase, transmembrane domains and EF hand metal and PDZ binding motif are
drawn below the encoding exons. Abbreviations SP: signal peptide; EF: EF hand metal binding motif; TMD: trans-membrane domain, P: PDZ binding
domain.
doi:10.1371/journal.pone.0003542.g003
Insect Neurexin and Neuroligin
PLoS ONE | www.plosone.org 7 October 2008 | Volume 3 | Issue 10 | e3542alternate stop codons (Figure 4.1, Table S1). Surprisingly, we
amplified cDNAs for each of the alternative 39-ends from brain
RNA, confirming two types of transcripts are generated from the
honeybee neurexin 1 gene (AmNrx1). The 39-end found through
homology searching was further authenticated using 39-RACE
analysis. Nested primers were specifically designed to the sequence
amplified cDNAs that encode C-terminal regions with adjacent
untranslated sequences (900 bp). This included a polyadenylation
site and a polyadenylated tail; thus confirming that the transcript
arose from bona fide mature mRNA (Figure S9).
Neurexin I is a ,400 kb gene containing 28 exons located on
chromosome 5 of the honeybee (Table 1). The two alternative stop
codons are located in exons 27 and 28 (Figure 4.1, Figures S4, S5)
and sequence analysis reveals exon 27 is absent from the honeybee
neurexin I amplicon possessing exon 28. Thus each form of the neurexin
I gene has a single stop codon. Exon 27 in the honeybee is
orthologous to the 39 terminal exon of DmNrxI. This arrangement is
in fact typical of all other characterised invertebrate and vertebrate
neurexins (FigureS4).Exon 28, on the other hand, represents a novel
arrangement. This form is denoted AmNrxI-B while the conventional
neurexin I variant using exon 27 is referred to as AmNrxI-A.
The mature AmNrxI-A and AmNrxI-B cDNA transcripts are
4.8 kb and 3.6 kb in size respectively (Table 1). They both span
nearly 400 kb of genomic sequence, and contain 27 or 23 exons,
respectively (Table 1). The first 22 exons are common to both,
whereas exons 23 to 27 are unique to AmNrxI-A and exon 28 is
only found in AmNrxI-B type transcripts (Figure 4.1). A similar
number of exons (23 or 24) encode the vertebrate neurexins.
Figure 4. Gene Arrangement and Alternative Splicing of Honeybee Neurexin I. The gene arrangement and intron/exon splice sites of
honeybee neurexin I and alternatively spliced transcripts were deciphered by both NCBI and Beebase BLAST tools against genomic DNA. Donor/
acceptor splice sites were confirmed using NCBI SPIDEY. Multiple protein alignment analysis by ClustalW demonstrated the conservation of intron/
exon splice sites (refer to Figures S4 and S5). Structural features were deciphered through PROSITE and SMART, and from Rissone et al. [109]; Jelen ´
et al. [71] and Sudhof et al. [110]. Exons are numbered from 59 to 3. The size of exons, intron gaps and protein domains (and compared to one
another) are not drawn to scale. Numbered arrows indicate sites of alternative splicing. (3.1) illustrates the full length neurexin I gene arrangement.
The common start codon is highlighted by ATG. The two alternate stop codons are highlighted by TAG(1) and TAG(2). Sites of alternative splicing
which occur within an exon are marked by a blue dot. Exons common to both the AmNrxI-A and AmNrxI-B transcripts are indicated above the gene
schematic. Exons unique to AmNrxI–A transcript with a transmembrane domain are indicated above the gene schematic. The exon unique to the
AmNrxI-B is labelled as ‘28’ and indicated as unique above. Horizontal primers below the gene schematic highlight the location of primers used for
RT-PCR amplification. AmNrxI-A was amplified with the forward primer at exon 1 (ATG) and the reverse primer in blue at exon 27 (TAG1). AmNrxI-B
was amplified with the same forward primer at exon 1 (ATG) and the reverse primer in red at exon 28 (TAG2). The protein domains which are
encoded by particular exons are shown below the specific exons. The transmembrane domain and putative PDZ domain of AmNrxI-B are shown
below exon 28. (3.2) illustrates the alternatively spliced AmNrxI-A and AmNrxI-B transcripts. (3.3) illustrates the alternate isoforms of AmNrxI-A and
AmNrxI-B which arise from alternative splicing. White arrowheads indicate where splicing occurs. Brackets above highlight neurexin repeats (two
complete LNS domains and an EGF motif). The putative PDZ domain of AmNrxI-B is hatched. Abbreviations- SP: signal peptide; E: EGF domain; T:
transmembrane domain; P: PDZ binding motif. LNS domain: Laminin, Neurexin, Sex hormone-binding globulin.
doi:10.1371/journal.pone.0003542.g004
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together with the human, fly, mosquito and nematode proteins to
determine a neurexin phylogeny. The translated honeybee
GB14382 sequence (CASPR ortholog) was also included in this
analysis (Figure 1.2). In contrast to the neuroligins, gene
expansion within the ‘neurological’ neurexin family only occurs
within the vertebrate lineage. The three vertebrate neurexin genes
form an orthologous group with the one invertebrate neurexin
gene (Figure 1.2). Like their vertebrate counterparts, the
invertebrate neurexin I may thus also have neurobiological
significance. The honeybee CASPR ortholog also has a Drosophila
ortholog (which has been called Drosophila neurexin IV; [66]
(Figure 1.2), and is expected to have non-neurological cell
adhesion functions.
As expected, neurexin amino acid identity scores are higher
among insects than between insect and vertebrates (55% and 30–
33%, respectively). Surprisingly however, human and honeybee
sequences are more alike in gene arrangement than honeybee is
to Drosophila. Of 26 predicted AmNrxI intron/exon splice sites,
12 are shared with human neurexins 1–3, with another four
intron/exon sites only slightly shifted between the species (25#
residues). Ten out of 12 Drosophila sites are shared among the
insect orthologs. The nematode neurexin I has 15 predicted
intron/exon splice junctions, but surprisingly not one of these
sites coincides with Drosophila neurexin I intron/exon splice
junctions, whereas four of them are shared with the honeybee
and human.
Neurexin I Proteins
Analysis by PROSITE [67] and multiple protein alignment
reveals obvious structural conservation between the characterised
human neurexins and fly (Drosophila) and honeybee neurexin I.
AmNrxI-A possesses a signal peptide, trans-membrane domain
and C-terminal PDZ binding motif, as in the vertebrate neurexins
(Figure 4.1 and Figure S4). As with their vertebrate orthologs (see
introduction), AmNrx-A also contains three repeats, each
consisting of two LNS (Laminin G-Neurexin-Sex hormone
globulin) domains and a central epidermal growth factor (EGF)
motif (i.e. three LNS-EGF-LNS repeats). AmNrxI-B is different to
AmNrxI-A in two respects. Firstly, the sixth LNS domain (i.e. the
second LNS in the third repeat) is incomplete in AmNrxI-B. LNS
domains, specifically the sixth domain, have been shown to be
involved in the invertebrate neurexin-neuroligin interaction
[68,69]. It is therefore reasonable to propose that AmNrxI-A
and AmNrxI-B isoforms may have different neuroligin binding
affinities. Secondly, AmNrxI-B lacks the trans-membrane domain
and PDZ binding motif encoded by exon 27 in AmNrxI-A,
suggesting that this isoform may be secreted or soluble (non-
membrane bound). Soluble isoforms of neurexin, retaining three
LNS-EGF-LNS repeats (Figure 4), have also been identified in
humans, albeit these result from premature in-frame stop codons
[70]. Due to the different genetic mechanisms by which soluble
neurexin products arise in the bee and humans, the recurrence of
this phenotype may be a case of convergent evolution. Interest-
ingly, AmNrxI-B contains a short C-terminal VKTGVC sequence
(exon 28) that encodes a conserved PDZ binding motif which
includes diagnostic hydrophobic residues adjacent to the final
cysteine [71,72]. The respective functions of the AmNrxI isoforms
will need to be determined experimentally; however, the primary
sequence analysis presented here suggests that AmNrxI-B may still
possess PDZ binding capacity. The physiological role of a soluble
PDZ binding neurexin isoform is not obvious. One possibility is
that this non-membrane form could interact with other, as yet
unidentified, PDZ-type proteins.
Neurexin I Alternative Splicing and Identification of a b-
neurexin like Isoform
The extent of alternative splicing of honeybee neurexin I transcripts
wasinvestigatedbyconductingtwo seriesofRT-PCRreactionsfrom
honeybee cDNA, using primers corresponding to the predicted start
and alternate stop codon regions of AmNrxI-A and AmNrxI-B.R T -
PCR analysis of AmNrxI-A identified a spliced variant that we have
called AmNrxI-A2 (Figure 4, Figure S5). AmNrxI-A2 results from the
use of two alternative splice sites which remove segments of the gene
corresponding to exons 4 and 6 of the full-length AmNrxI-A cDNA.
Whereas AmNrxI-A possesses three LNS-EGF-LNS repeats, the
putative AmNrxI-A2 isoform lacks part of the first EGF and second
LNS domains. The first site of alternative splicing in AmNrxI-A2 is
equivalenttothefirstsiteofalternativesplicinginthehumanneurexins
(Figures S4, S5; [7]. In contrast, the second site of alternative splicing
is unique to the honeybee. Of the four other alternative splice sites in
the human neurexin, sites 2 and 4 coincide with intron/exon splice
junctions in the honeybee gene.
RT-PCR analysis of AmNrxI-B identified ten alternatively spliced
transcripts (denoted AmNrxI-B-B10 in order of decreasing size;
Figure 4, Figure S5). These ten transcripts arise through the
differential use of twelve sites of alternative splicing. Eight of twelve
splices sites occur within exons, while the remaining four occur at
intron/exon boundaries. Interestingly, AmNrxI-B7 contains an
additional 72 bp exon (11) not found in any other AmNrxI-A or
AmNrxI-B type transcripts. Thus, compared to this variant, AmNrxI-A
infactpossessesthreesitesofalternativesplicing,not twoaswould be
inferred by comparison to AmNrxI-A2. It is possible that an AmNrxI-A
transcript possessing exon 11 (plus all other exons in AmNrxI-A) exists
within the honeybee transcriptome but was not detected in the tissue
anddevelopmentalstagesanalysedhere.Exon11encodespartofthe
third LNS domain (the first LNS of the second repeat).
Across the A and B forms of neurexin I, all of the alternative splice
sitesexceptsplicesites2and3occurwithinLNSdomains,suggesting
alternative splicing will affect the neuroligin binding properties of
these isoforms(Figure 4). In particular, the use of splicesites 1, 5, 7, 8
and 11 in AmNrxI-B, B2, B7, B8 and B10 give rise to truncated LNS
domains. In addition to the truncated LNS domains, B family
variants also differ in the number of LNS-EGF-LNS repeats. Full
length human neurexin possesses three such repeats [18]. This
arrangement is conserved in AmNrxI-A, -A2, -B and -B2, however
AmNrxI-B3 to AmNrxI-B6 possess only two LNS-EGF-LNS
repeats, and AmNrxI-B7 and -B8 possess just one (Figure 4). No
such arrangements have been reported in neurexin literature before
and raise interesting questions as to the function of these isoforms.
The AmNrxI-B9 and -B10 isoforms have a single LNS domain
structure as per the vertebrate b-neurexins (Figure 4) [18].
Importantly, exon 28 is longer in AmNrxI-B9 than in the other
identified AmNrxI-B splice transcripts in which it is truncated
(Figure 4). Because the full sequence of exon 28 encodes a trans-
membrane domain immediately upstream of the putative PDZ
binding domain (Figure 4, Figure S5), it is likely AmNrxI-B9 will be
membrane bound and thus structurally similar to vertebrate b-
neurexins. Furthermore, exon 28 of AmNrxI-B9 contains a serine
rich region directly upstream of the trans-membrane domain (Figure
S5); a similar serine-rich region, associated with O-glycosylation and
a feature of cell surface receptors, is also found in the human
neurexins where it confers trans-membrane orientation [17,18].
Conservation of the Neuroligin-Neurexin Interface in
Honeybee
A homology model of AmNrxI-A was constructed using the
recently crystallised neuroligin binding domain of mouse b-
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of two 3 amino acid insertions in the AmNrxI-A sequence, the
domains aligned well and their overall sequence identity was
relatively high (42%; Figure S8). Sequence identity was consider-
ably higher in the protein core (58%) than the solvent exposed
regions (25%), reflecting the selective pressure to maintain the
same tertiary fold (Figure 2.1c). The exception to this trend was
the neurexin-neuroligin interface, which unlike the rest of the
protein surface, was highly conserved: of the thirteen residues that
are buried to some extent upon neuroligin binding, six were
identical (N103, P106, R232, I243, N238, S239), four were highly
conserved (R109K, S132A, V154M, I236V) and three were semi-
conservative differences (S107E, T108M, L135S). Importantly, the
residues known to form salt bridges across this domain were
conserved (R109K, R232). The calcium binding site residues
(D137, V154, I234 and N236), essential for the neuroligin-
neurexin interaction [51], are also located at this region and are
also conserved, with the main chain carbonyl atoms of M145 and
V236 being appropriately positioned with respect to the side
chains of the analogous residues (D137 and N238) in neuroligin
(Figures S6 and S7). Considering that there are million of years of
divergent evolution between the bee and mouse, the similarity
between these regions across the vertebrate and invertebrate
neurexins suggests strong selective pressure to maintain this
binding interface.
The complementary binding surface of the bee neuroligin 1 also
shows moderate albeit incomplete conservation with vertebrate
neuroligins.In AmNLG1, thelevel ofconservation waslessthanthat
observed in AmNrxI, but was still significant: D387 and D402 are
retained in AmNLG1 at each end of the interface (Figure S6) to
potentiallymaintain a saltbridge and hydrogen bond with R232 and
N103ofAmNrxI-A,respectively(Figure2.4,FigureS8).Thereisless
sequence identity in the central region of the interface in AmNLG1,
although the hydrophobic character (G396P, F398F, F499A) and
hydrogen bonding capability (Q395N, E397Q, N400R) of these
residues are largely retained (Figure 2.4, Figure S8).
In contrast, the putative neuroligin-neurexin interface in
AmNLG3 is remarkably divergent: of the eight residues that
become buried on neurexin binding in MmNLG1, only D402 is
conserved (Figure S7). Of particular note, both residues involved
in salt bridges (D387P, N400R) are absent. In addition, there is a
three amino acid insertion in the loop where the majority of the
residues that form the interface are located (395–402) and a
sixteen amino acid insertion immediately preceding it (Figure S7).
Without over-interpretation of these models, we feel it is
reasonable to propose the nature of the neuroligin-neurexin
interaction will be conserved between vertebrate and invertebrates
in the case of AmNrxI and AmNLG1. In contrast, it appears
unlikely that AmNLG3 will interact with AmNrxI, at least in the
same fashion as vertebrate NLG1 and b-Nrx 1. However, without
resolution of the AmNLG3 and AmNrxI-A protein structures or
other experimental means, this interaction cannot be ruled out.
Furthermore, given differences in binding affinities have been
documented between the human neuroligins and neurexin 1 [51],
it is feasible to suggest that different binding affinities or interfaces
exist between the bee neuroligins and neurexin I, thus shedding
light on the differences seen by homology modelling of the
AmNLG1-AmNrxI-A and AmNLG3-AmNrxI-A interactions.
Expression Analyses
To elucidate expression patterns of honeybee neurexin I and the
neuroligins in the developing brain, quantitative real time PCR
(qRT-PCR) was performed from whole larvae RNA, pupal brain
RNA and adult brain RNA of newly emerged, 3 day, 7 day and
forager bees. For this work, primers were designed to regions of
each gene that are common between the alternatively spliced
transcripts (Table S1); thus, the profile for each gene should
encompass all of the transcripts detected thus far.
Expression of neurexin I and the neuroligins was found throughout
development, from larvae to adult life stages (Figure 5, Table 3).
Expression ofneurexinI and neuroligins 2,3,4 and 5 generally increases
through development, with particularly pronounced up-regulation
from pupal to adult stages. Neuroligin 3 increases about 9 fold from
early larvae to newly emerged adults (female worker bees), while
neurexin I, neuroligin 4 and neuroligin 5 expression increases approxi-
mately25–40foldoverthisperiod.Theexpressionofbothneuroligin3
and 5 appears to drop slightly at one-week post adult emergence.
Neuroligin 2 shows the greatest change through development, with a
140-fold increase in expression through early developmental to adult
stages. At the other extreme, neuroligin 1 shows a consistent level of
expression throughout development. It is also one of the most highly
expressed neuroligins in the larval sample, although this could
represent expression outside the central nervous system since whole
larvae were analysed as opposed to only brain tissue at other
developmental stages.
qRT-PCR experiments show that all of the honeybee neuroligin
genes and neurexin I are also expressed outside of the adult brain; in
the thorax, legs, abdomen and wings (Figure 6, Table 4).
Expression levels (relative to the housekeeping gene Ribosomal
Protein L8 (RPL8)) are still significantly higher in the brain
compared to other tissues for neuroligins 2–5 and neurexin I but
neuroligin 1 expression is much greater in tissues outside of the
brain. This suggests a putative role for neuroligin 1 in the peripheral
nervous system in addition to the central nervous system,
potentially with importance at neuro-muscular junctions. Further-
more, significant expression of neuroligin 1 in the wings and legs
(Table 4) suggests a putative role in nerve endings responsive to
sensory input. Interestingly, human neuroligin 4X displays a similar
expression profile to honeybee neuroligin 1, with low levels of brain
expression and higher expression levels outside of the brain [4,74].
Human neuroligin 4X, however, has been established as a critical
molecule required for proper neuro-connectivity [39,41,42],
illustrating that the relative distribution or expression level of a
gene is not necessarily informative of its functional priorities. Thus
the low levels of neuroligin 1 expression in the honeybee brain may
not necessarily suggest a trivial role. On another note, although
neuroligins are expressed outside of the central nervous system in all
characterised species, neurexin expression is strictly restricted to the
human and rodent brain, suggesting that honeybee neurexin I has
greater functional diversity than that seen in vertebrates.
In situ hybridisation was used to investigate the distribution of
neurexin I (AmNrxI-A and AmNrxI-B) and neuroligin 3 (AmNLG3)
within the honeybee brain. In order to detect the expression of all
possible RNA transcripts, probes were again designed to regions
that are common to all alternatively spliced transcripts. Specifi-
cally, the probes used to investigate AmNrxI-A and AmNrxI-B
expression were designed to the common 59 region of the gene.
The probes used to investigate AmNLG3 expression were not
designed to the cholinesterase region where splicing is localised,
but instead to the first and last exons of the gene which are
common to all alternatively spliced transcripts.
AmNLG3 is predominantly found in the mushroom body of the
adult brain, with some expression also in the cell bodies of the
optic lobes, antennal lobes and central body (Figure 7.1). A
broadly similar distribution pattern is seen for AmNrxI whereby the
transcripts are predominantly localised to the mushroom body of
the adult brain (Figure 7.2). However, expression of AmNrxI is
more dispersed throughout the pupal brain than in the adult,
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development and a more specific role in the adult brain.
The mushroom body in insects is considered the centre of
higher order processing and a functional analogue of the
hippocampus in vertebrates [75,76]. The optic and antennal lobes
relay visual and olfactory stimuli to the mushroom bodies [77,78],
thus the expression of AmNLG3 and AmNrxI in these tissues is
consistent with a role for these products in sensory signalling and
cognitive processing. Changes in neuroligin and neurexin I gene
expression in association with training bees under memory and
learning tasks have been observed (S.Biswas unpublished), further
strengthening the significance of this observed expression. A role
for neurexin I in synaptogenesis and cognition has also been
demonstrated in Drosophila, where neurexin I null mutants were
found to exhibit decreased synapse number and associative
learning defects [65].
A closer examination of the in situ hybridisation images revealed
a difference between the expression patterns of neuroligin 3 and
neurexin I in the mushroom bodies. The mushroom body is made
up of four encircling ‘cup like’ structures called calyces, each filled
Figure 5. Developmental Expression Profiles of the Neuroligins and Neurexin I in Honeybee Brain. Honeybee neuroligin and neurexin I
expression was assessed by quantitative real time PCR amplification. The ribosomal gene RPL8 was used as the housekeeping gene. Methodology for
data analysis and the presentation of results was taken from Collins et al [104]; where by expression levels were normalised by subtraction against the
threshold cycle of the RPL8. Collins et al [104] found RPL8 to be the best correlate with RNA concentration across varying developmental life stages
and varying tissues of the honeybee. Expression levels were examined from whole larvae (5 day old); and brain tissue from pupae (stage P8 as
outlined by Ganeshina et al [101]) 24 hour adult, 7 day adult and forager honeybees. Standards errors were negligible and less than +/21.18 for all
experimental results. The coloured lines illustrate the developmental expression profile of a single gene through development. Data points in
columns illustrate the relative levels of neurexin I and neuroligin expression to one another at a particular stage of development. The developmental
stage/gene with lowest expression relative to the control gene (neuroligin 1 at 7 days of age) was given an arbitrary expression level of 1. The data
values are shown in Supplementary Data Table 3.
doi:10.1371/journal.pone.0003542.g005
Table 3. Relative (Fold) Differences in Expression of
Honeybee Neuroligins and Neurexin I through Development
(Illustrated in Figure 5).
larvae pupae newly emerged 7 day forager
neurexin I 5.26 4.35 59.65 84.45 121.1
neuroligin 1 4.16 1.29 2.27 1 1.25
neuroligin 2 1.02 4.26 52.41 105.42 140.07
neuroligin 3 6.25 12.91 42.96 38.59 54.95
neuroligin 4 2.04 2.69 22.34 39.95 79.99
neuroligin 5 1.1 4.06 22.16 20.25 28.34
*numbers indicate relative fold difference in expression level of genes
compared to one another, and relative fold difference in expression level of a
single gene through development–all values normalised to RPL8. Raw data
shown in Supplementary: Table A3, A3i and A3ii.
doi:10.1371/journal.pone.0003542.t003
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cells are subdivided into two morphologically distinct types, the
large-type and small-type Kenyon cells [78,81]. Interestingly,
expression of neuroligin 3 was higher in the small-type central
Kenyon cells than in the large-type peripheral Kenyon cells
(Figure 7.3a). The reverse was seen for neurexin I, which was more
highly expressed in the large-type than small-type Kenyon cells
(Figure 7.3b). This difference is intriguing given the trans-synaptic
partnership between neuroligins and neurexins [82–84] would predict
a parallel expression pattern. On the other hand, differences in
RNA localisation in the Kenyon cell bodies do not necessarily
reflect the distribution of synaptic proteins that can be distantly
localised on axonal projections in the neuropil [77,78].
An immunohistochemical analysis was therefore conducted to
assess the localisation of the honeybee neurexin I protein in the
bee brain. For this we used a Drosophila neurexin I polyclonal
antibody provided by Professor Wei Zie (Department of Genetics
and Developmental Biology, Genetics Research Center, Southeast
University Medical School, China; [65]) which cross reacts with
honeybee neurexin I (Figure 8). As with the Zeng et al. [65] study,
we used the monoclonal antibody to Drosophila synapsin (SynOrf-
1), known to cross hybridise with other insect synapsin proteins, as
a parallel synaptic marker [85].
Our results showed a distribution of honeybee neurexin I and
synapsin that is broadly similar to the pattern described for
Drosophila (Zeng et al. [65]; Figure 8). Honeybee neurexin I
expression generally appears to be associated with the neuropil of
the brain (Figure 8) encompassing dendrites, axons and glial
processes but excluding neuronal cell bodies. The expression of
bee neurexin I is thus distinct from the expression of the neurexin I
transcript in cell bodies, as shown by the in situ hybridisation data,
and is broadly similar to the expression pattern of other insect
synaptic proteins [65,86]. Furthermore, the expression of bee
neurexin I protein in the mushroom body neuropil is consistent
with the localisation of the transcript, given that the arrangement
of Kenyon cell processes are known to extend into the mushroom
body calyx neuropil and lobes [77,78]. Neurexin I localisation in
the optic and antennal lobe neuropils is also consistent with the
transcript data, seen juxtaposed with observed mRNA expression
in cell bodies associated with the optic lobes and antennal lobes
(Figure 8).
Neurexin I expression was also detected in several solitary thin
neural processes which showed clear and relatively strong
fluorescence scattered throughout the brain (Figure 8). For
example, immuno-reactive neurites between the inner surface of
the calycal neuropile and the Kenyon cell somata clusters were
seen in the mushroom bodies. These are typical of the extrinsic
neurons of the mushroom body which project into the calyx [77].
In the optic lobes, immuno-reactive neurites were found arranged
in a rather regular, radial pattern suggesting bee neurexin I
expression may be found in either centripetal or centrifugal optic
lobe interneurons [77].
Some differences in the localisation of honeybee neurexin I,
distinct to synapsin, were also identified. Neurexin I expression
Figure 6. Spatial Expression of Neuroligins and Neurexin I in the Adult Honeybee. The methodologies behind attaining these results are as
described in the Figure 5 legend. Expression levels are shown relative to the house keeping gene RPL8, given an arbitrary value of 1. Expression levels
were examined from the tissue of ten adults at twenty-one days of age. Standards errors were negligible and less than +/21.22 for all experimental
results. Level of gene expression in the brain expression shown in the dark purple columns marked B, wings in the light grey columns marked W, legs
in the light purple columns marked L, thorax in the dark grey columns marked T and abdomen in the blue columns marked A. Raw data from the
qRT-PCR experiments in Supplementary Data Table 4.
doi:10.1371/journal.pone.0003542.g006
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within the optic lobe stratum (Figure 8), possibly suggesting a
special role for neurexin I in the visual system of the bee. Given
synapsin is a vesicular protein found at the synapse, the more
widespread expression of neurexin I suggests it is expressed beyond
the synapse. This is not surprising given the broad range of
neurexin I isoforms which have been detected in the bee (e.g.
membrane and putatively soluble) with potentially distinct
migration modes and functions.
Discussion
The eumetazoan synapse is thought to have evolved over one
billion years ago [87]. Many pre-existing proteins were recruited
for their various functional properties (adhesion, catalysis) to form
synaptic proteins such as neuroligins [88] and provided the
molecular foundations for the evolution of the central nervous
system synapse. Our study of honeybee neurexin I and the neuroligins
confirms significant levels of conservation exist between insect and
vertebrate synapses. An equivalent number of neuroligins are found
in humans and honeybee, and together they form an orthologous
group that diverged from an acteylcholinesterase-type molecule in a
sea squirt-like ancestor (Claudianos et al. unpublished). Both
vertebrate and invertebrate neuroligins are single type-1 trans-
membrane proteins that typically contain a cholinesterase domain
andC-terminalPDZbindingmotif.HoneybeeneurexinIalsoshares
a deep-rooted common origin and structural topology with the
vertebrate neurexins. The exceptional levels of intron/exon splice
site conservation, giving rise to similar neurexin and neuroligin
isoform patterns between vertebrate and honeybee, suggests that the
function of these molecules may essentially remain the same.
We may not have recovered all of the splice variants of neuroligin 3
that the honeybee normally produces, but the five splice variants we
have recovered already represent a greater diversity of splice forms
than those currently reported for the vertebrate neuroligins.S o m eo f
the honeybee variants are truncated forms missing whole exons
which encode domains deemed important to the regulation of
binding witha-neurexins[16].Interestingly,someofthebeevariants
mimic alternatively spliced transcripts found in individuals affected
by autism [63]. These splicing patterns raise interesting questions as
to how these alternate isoforms function inthe honeybee considering
their vertebrate counterparts appear to have detrimental effects.
The alternative splicing of neurexin I in the honeybee generates
even greater diversity. Ten alternatively spliced transcripts of neurexin
I arise from twelve alternative sites. Conservation of these sites, to
sites used for alternative splicing in the human neurexins [89]
suggests that there is some parallel constraint in the two systems. On
the other hand, novel honeybee splice variants of neurexin I,
unreported in vertebrates, suggest the possibility of some differences
in functional roles for neurexin I in the bee. The honeybee has two
predominant types of isoforms arising from two alternate 39 exons.
Both types encode C-terminal regions containing a typical trans-
membrane domain and PDZ binding motif. In the vertebrate
lineage, a-neurexins consist of three ‘‘LNS-EGF-LNS’’ repeats,
while b-neurexins possessa single LNS domain, the two typesarising
from the use of two alternate promoters [18]. In this regard we also
see neurexin I transcripts in the bee with varying patterns of ‘‘LNS-
EGF-LNS’’ repeats, including a-neurexin types with three classical
repeats and those which encode a single LNS domain as for
vertebrate b-neurexin. However, we also identified transcripts with
two LNS-EGF-LNS repeats. We speculate that the presence of
alternate39 regionsmaintainsextensiveneurexinsplicing diversitythat
otherwise arises from a separate a-a n db- promoter reported in
vertebrates. Moreover, the complexity discovered by honeybee
neurexin I could perhaps represent a greater evolutionary investment
inasinglegeneamonginvertebratesthatisoffsetbymultipleneurexins
in the vertebrate lineage.
Surprisinglywealsoidentified splicevariantsofneurexinIinthebee
which give rise to putative soluble isoforms. Some earlier vertebrate
studies similarly support the existence of putative soluble neurexin
isoforms [70], raising the possibilitythat there are otherintegral roles
for these molecules which to date remain unexplored. Such
molecules, including truncated forms of neurexin I and neuroligin
(i.e. mimicking autism variants, missing EF metal binding motifs),
could serve regulatory roles by attenuating the function of full-length
isoforms or behave as soluble signalling molecules [63,70]. These
molecular observations in the honeybee arguably suggest a diverse
range of neuroligin-neurexin interactions that need to be either
confirmed to be similar or absent in vertebrates. Extensive life stage
samplingand labourintensivecloningand sequencecharacterisation
of RNA products remains the only effective tool. Understanding
precise mechanisms of binding and oligomerisation, including what
Table 4. Relative (Fold) Differences in Expression of
Honeybee Neuroligin and Neurexin I Spatial Expression in the
Adult (Illustrated in Figure 6).
Gene Tissue
Expression Level
Relative to RPL8
Expression Level Relative
to Brain Expression
RPL8 (housekeeping) 1.0000
NrxI Brain 0.1073 1.00
Wing 0.0080 13.45 fold LESS
Leg 0.0043 24.85 fold LESS
Thorax 0.0089 12.13 fold LESS
Abdomen 0.0043 24.85 fold LESS
NLG1 Brain 0.0011 1.00
Wing 0.0082 7.390 fold MORE
Leg 0.0073 6.620 fold MORE
Thorax 0.0176 15.83 fold MORE
Abdomen 0.0013 1.140 fold MORE
NLG2 Brain 0.1285 1.00
Wing 0.0014 88.650 fold LESS
Leg 0.0019 67.420 fold LESS
Thorax 0.0059 21.710 fold LESS
Abdomen 0.0008 161.46 fold LESS
NLG3 Brain 0.0487 1.00
Wing 0.0046 10.48 fold LESS
Leg 0.0040 12.13 fold LESS
Thorax 0.0137 3.560 fold LESS
Abdomen 0.0035 13.91 fold LESS
NLG4 Brain 0.0713 1.00
Wing 0.0022 31.78 fold LESS
Leg 0.0028 25.46 fold LESS
Thorax 0.0078 9.090 fold LESS
Abdomen 0.0008 86.52 fold LESS
NLG5 Brain 0.0251 1.00
Wing 0.0009 26.63 fold LESS
Leg 0.0014 18.00 fold LESS
Thorax 0.0080 3.150 fold LESS
Abdomen 0.0009 27.76 fold LESS
doi:10.1371/journal.pone.0003542.t004
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interaction between neurexin I and the neuroligns, remains a high
priority.
The RNA and protein localisation data leave us with a number
of questions concerning synaptic connectivity in the insect brain.
Antibody staining shows neurexin I is associated with the
surrounding neuropil, which largely represents dendritic arborisa-
tion including the calycal cups of the mushroom body. This
neurite association overlays the expression of other synaptic
proteins such as synapsin and Drosophila Nrx1 [65]. In situ RNA
staining confirms neurexin I and neuroligin expression is associated
with closely neighbouring cell bodies throughout the brain. We
also see an intriguing differential expression pattern between
neurexin I and neuroligin-3 juxtaposed in subpopulations of Kenyon
cells in the mushroom body. Neurexin I and the neuroligins may
thus provide important functional markers for analysing neural
circuitry in the bee brain. As reported by a number of studies,
neuroligins and neurexins have a role in memory and learning
defects that result in documented neurological disorders such as
autism. Neuroligin and neurexin gene knockout studies contrast a
high molecular conservation with the lack of an obvious role in
early development. We therefore postulate that the neuroligin/
neurexin complex is selectively constrained through evolution
because it primarily participates in post-natal and/or adult sensory
synaptic plasticity. The honeybee is a sophisticated behavioural
model with which to study learning and memory including sensory
processing [47]. We have shown these molecules have a high
evolutionary conservation spanning hundreds of millions of years
and thus establish an important prerequisite for using the bee as a
model for vertebrate synaptic development. Dissecting the role
neuroligins and neurexin I play in the bee brain is a challenge
worth accepting.
Materials and Methods
Bioinformatics
Putative neurexin and neuroligin genes were identified in the Apis
mellifera (honeybee) genome by homology-based searches using the
BLAST tools from NCBI (http://www.ncbi.nlm.nih.gov) and
Beebase (Honeybee Genome Database by Baylor College of
Figure 7. Neuroligin and Neurexin I Brain Expression. To identify RNA transcript distribution, in situ hybridisation experiments were performed
on 20 mm honeybee brain sections using gene specific digoxygenein labelled probes: (7.1) illustrates expression of AmNLG3 in the adult brain of
newly emerged (left) and forager (right) bees. Top images illustrate results of anti-sense probe staining. Bottom images illustrate the results of the
negative control experiments using a sense probe. (7.2) Expression of AmNrxI/AmNrxI_28 in both a P8 stage (outlined by Ganeshina et al. [101]) pupae
(left) and adult forager (right) honeybee brain. Top images illustrate the results of anti-sense probe staining. Bottom images illustrate results of the
negative control experiments using a sense probe. (7.3) shows contrasting AmNLG3 and AmNrxI expression in the adult mushroom body. (a) AmNLG3
expression higher in the small Kenyon cells. (b) AmNrxI expression higher in the large Kenyon cells. Abbreviations- MB: mushroom body; OL: optic
lobe; AL: antennal lobe; L: large Kenyon cells; S: small Kenyon cells.
doi:10.1371/journal.pone.0003542.g007
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honeybee neuroligin sequences were assembled using homology-
based searching of the honeybee genome with the Drosophila
(CG31146; CG13772; CG34127; CG5030) and Anopheles gambiae
(mosquito) (COEnrl2B; C40C9.5; COEnrl1B; COEnrl8o;
COEnrl16o) neuroligin sequences. Similarly, to assemble putative
honeybee neurexin sequences, Drosophila neurexin sequences
(CG7050, CG6827) were used in homology-based searches.
In conjunction with the homology-based searches, putative gene
predictions were assembled together with information from
predicted in silico sequences provided by Beebase, albeit the
homology-based gene predictions produced sequences with higher
sequence identity to characterised vertebrate neuroligin and neurexin
genes. Sequence from the following seven Beebase (GB) gene
predictions partially matched the homology-based gene predic-
tions found from using the respective Drosophila (CG) and mosquito
(CO) neuroligin sequences: (1) GB18720/CG31146/COEnrl2B; (2)
GB10066/CG13772/C40 C9.5; (3) GB18290/CG34127/
COEnrl1B; (4) GB18836/CG34139/COEnrl8o; (5) GB13939/
COEnrl16o; (6) GB18754/CG7050; (7) GB14382/CG6827.
BLAST analysis helped identify the chromosomal position and
gene arrangement of the cloned honeybee transcripts. Sequence
analysis tools SPIDEY [59], ExPASy [67], PROSITE [67],
SMART [90,91] and CDART [92] helped predict protein motifs
of the neuroligins and neurexins (outlined in Supplementary Data).
ClustalW [93] multiple protein alignments were used to construct
phylogenetic trees as determined by the Neighbor Joining method
with bootstrap re-sampling (detailed in the legends for Figures 1),
using MEGA3.1 [94]. Congruent tree topology was observed
using maximum parsimony analysis [94].
Homology Modelling
The sequences of AmNLG1, AmNLG3 and the mouse NLG1
sequence [51], were downloaded from Swiss Prot [95] (accession
number Q99K10) and were aligned using the T-COFFEE server
[96]. Using these alignments, the sequences were threaded onto
the templates using the program DEEP VIEW [97]. Preliminary
models were then optimized using the SWISS-MODEL work-
space [98], which succeeded in ligating all loops and minimizing
the structure. The robustness of the structure was monitored
through analysis of plots of the Anolea mean force potential [99]
and GROMOS [100] empirical force field energy, as implement-
ed in the workspace. All structures were of good quality, consistent
with the quality of the alignments.
Brain and Tissue Dissection and RNA Extraction
All bees used in these analyses were worker females. Larval
samples were collected 5 days after hatching and pupae at stage
P8, as per established developmental criteria in Ganeshina et al
[101] (see Table 1). To collect adult bees, a single brood frame was
obtained from the hive and placed in an incubator at 32uC (80%
humidity). Newly emerged adult individuals were collected within
5 minutes of emerging from their cell. Bees were used immediately
for dissection of fresh tissue, or caged and returned to an incubator
at 32uC (80% humidity) for harvesting at days 3 and 7 post
emergence. Forager bees that typically carry pollen aged between
21 to 35 days were captured near the hive entrance and similarly
used for fresh tissue. Bees were cold anesthetised and brain tissue
dissected. The head was separated from the body and frontal
section of the head capsule removed to reveal the brain. The
exposed brain was placed in diethyl pyrocarbonate (DEPC) treated
Figure 8. Honeybee Neurexin I Protein Expression in the Brain. Immuno-staining of forager brain sections (a) for synapsin using SynOrf-1
antibody and incubation with Alexa-488-conjugated anti-mouse antibody allowing green colouration to highlight protein expression; (b) for
honeybee neurexin-I using DmNrx-1 antibody and incubation with Alexa-546-conjugated anti-mouse antibody allowing red colouration to highlight
protein expression; (c) merge shows neurexin-I and synapsin co-localise in mushroom body neuropil (MB medial lobe and MB calyx), optic lobe
neuropil (medulla and lobulla) and antennal lobes. Small puncta of neurexin I expression, distinct to synapsin, are highlighted by small arrow heads
within the optic lobe (OL) stratum.
doi:10.1371/journal.pone.0003542.g008
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placed in a tube on dry ice for immediate RNA extraction.
Total RNA was isolated form 10–20 frozen brains using the
Trizol reagent method (Invitrogen Life Technologies). Adult brain
RNA pellets were resuspended in 20–60 ml of distilled water,
depending on the downstream application and desired concen-
tration. RNA extraction from whole larvae and adult wings, legs,
thoraces and abdomens was performed with the same protocol as
above, with the following details; RNA from two larvae was
resuspended in 100 ml of distilled water. RNA extraction from the
wings, legs, thoraces and abdomens of 10 bees was pooled and
resuspended in 60 ml of distilled water. Total RNA used for RT-
PCR amplification was treated with DNase I (Invitrogen: #18068-
015). 2–4 ml of this RNA was then used for gel electrophoresis to
assess the integrity of the extraction using a 1.5% Tris-Acetate-
EDTA (TAE) gel made with DEPC-treated water and run in
DEPC-based TAE buffer. RNA samples used for quantitative real
time PCR were then quantified by spectrophotometry using a
Nanodrop (Biolab: # ND1000; V3.2 software).
General Molecular Methods
The honeybeeneuroliginand neurexinI transcripts were identified by
RT-PCR amplification using the SuperScript III One-Step RT-
PCR System with PlatinumH Taq DNA Polymerase (Invitrogen: #
12574-018/026). Table S1 (Supplementary Data) outlines the
primer sets (synthesised by Geneworks, Australia), cDNA samples
and PCR conditions used for amplification of each gene. (EcoRI sites
were designed in the primers). RT-PCR amplicons were visualized
using low melt TAE agarose gels and desired bands extracted for
10 ml in-gel ligation reactions performed overnight at 16uC, with the
cloning vector pGEMH-T Easy (Promega: # A1380). 50 mlo f
distilled water was then added to each reaction and competent
JM109 E.coli cells (Promega: #L2001) were chemically transformed
with 10 ml of the diluted ligation reaction as per standard methods
and grown overnight at 37uC on LB (Luria broth) agar media
supplemented with ampicillin using standard (X-Gal/IPTG) blue/
white selection. Single E.coli colonies were used to inoculate 10 ml of
LB with 20 mlo f5 0mg/mL ampicillin, and grown overnight at 37uC
shaking. The plasmids were recovered using the QIAprep Spin
Miniprep Kit (Qiagen: # 27104). Diagnostic restriction digests with
EcoRI [102] were performed to check the fidelity of ligation. Plasmid
DNA was then quantified by spectrophotometry with a Nanodrop
(Biolab: # ND1000; V3.2 software) and sent for sequencing with
M13 universal primers by Micromon Services (http://www.
micromon.monash.org/). Gene specific primers were then designed
to sequence longer amplicons.
39RACE
Nested 39RACE (Rapid amplification of cDNA ends) primers
used to confirm exon 28 in A.mellifera neurexin I (AmNrxI-B) are
outlined in Table S1. Total RNA was isolated from the brain tissue
ofa 3dayoldbee and treated with DNaseIusingthe RNAqueousH-
Micro Kit, following the manufacturer’s instructions (Ambion). First
strand reverse transcription reactions were carried out following the
manufacturer’s instructions using SuperScript
TM III Reverse
Transcriptase (Invitrogen). The 39 RACE cDNA synthesis reaction
was primed with the 39 RACE Adapter (Table S1). Additionally,
positive and negative control reactions with oligo (dT)18 were
performed. The negative control contained no reverse transcriptase.
The control reactionswereperformed with the (dT)18 primed cDNA
reactions using primers specific for Synaptotagmin in A.mellifera, SYT-F
and SYT-R (Table S1).
1 mL of template was used for each PCR with 1.5 U Taq
polymerase (Fermentas) in 50 mM KCl, 3 mM MgCl2, 10 mM
Tris HCl (pH 9), 0.08% Nonidet P40 and 0.4 mM of dNTP’s in a
25 ml volume. PCR conditions used an initial denaturation (5 m at
95uC), followed by 30 or 35 cycles (30 s at 95uC, 45 s at 52uCo r
55uC, 2 m at 72uC). For the first round of amplification of the 39
end, the cDNA reaction primed with the 39RACE Adapter (Table
S1) was used as template and 39RACE Outer Primer and
AmNrx1ex28_59_2 were the primers (Table S1). These PCR
reactions were performed for 35 cycles with an annealing
temperature of 52uC. For the second round of amplification of
the 39 end, primers internal to the first round PCR product were
used. The first round PCR was used as template with the 39RACE
Inner Primer and AmNrx1ex28_59_3 as the primers (Table S1).
These PCR reactions were performed for 30 cycles with an
annealing temperature of 55uC. PCR products appearing in the
second reaction were separated by agarose electrophoresis and
cloned into pGEM-T Easy (Promega) and sequence verified. The
SYT positive control reaction generated the expected product of
200 bp, and the negative control yielded no product. Analysis of
the sequences confirmed a 39 untranslated region, spanning
870 bp from the (exon 28) stop codon TAG to the polyA tail.
Quantitative Real Time PCR (qRT-PCR) Amplification
Primers used to analyse the expression of honeybee neuroligins and
neurexin I were manually designed and then verified by PRIMER
[103]. All primers were designed to work at similar annealing
temperatures and to generate similar sized PCR amplicons. The
primer sets were first checked with standard PCR amplification and
gel electrophoresis (2.5% TAE, 25 bp ladder Promega:
#19928601), and then used in a test qRT-PCR experiment to
assessprimerspecificity.Allprimersetswerehighlygene-specificand
produced a single dissociation/melting (Tm) curve. Positive control
reactions used primer sequences for the housekeeping gene Ribosomal
Protein L8 (RPL8) that has been shown to be the best correlate with
RNA concentration across varying honeybee developmental life
stages and tissues [104]. Table S1 outlines the primers sets that were
used, all at an annealing temperature of 55uC. Brain dissections and
total RNA extraction were as outlined above. 1 mg RNA was used in
a2 0mL cDNA synthesis reaction, using the IScript cDNA synthesis
kit (Bio-Rad #170-8891). cDNA samples were then used at a
dilution of 1:20. The qRT-PCR reactions were set up with an
automated liquid handling instrument (Beckman Coulter: BiomekH
3000) into 96 well PCR plates (Bio-Rad: #2239441), and performed
in triplicate. Each reaction was 25 mLs in total volume, composed of
10 mL1 : 2 0c D N As a m p l ea n d2 5mL master mix (12.5 mL ITaq
SYBR Green Super-mix with ROX (Bio-Rad: #170-8850), 0.5 mL
10 mm forward primer, 0.5 mL1 0 mm reverse forward primer,
1.5 mL water). Each master mix was prepared immediately before
the experiment and kept in darkness as much as possible. qRT-PCR
amplification was performed by the ABI PrismH 7000 Sequence
Detection System (Applied Biosystems, 7000 SDS Instrument),
Version 1:2:3. The relative quantification (ddCt) assay default
settings were used, with the addition of an extra 15 second annealing
step at 55uC. Relative quantification and standard deviation
calculations were derived by the comparative method (outlined by
Applied Biosystems). Methodology for final data analysis and the
presentation of results was taken from Collins et al [104], whereby
expression levels were normalised by subtraction against the
threshold cycle of RPL8.
In situ Hybridisation
The protocols for in situ hybridisation were taken from Vidovic et
al. [86]. Detailed methodology and modifications to the published
protocol are provided in supplementary data (Materials and
Methods S1). Six brainsectionswere assayed for eachgene category.
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Adult worker bees were caught at the hive entrance, anesthetized
by cooling and sacrificed by decapitation. Brains were dissected free
and fixed in 4% freshly depolymerised paraformaldehyde in 0.1 M
phosphate buffer(pH 7.3).Afterthoroughrinsing inthesamebuffer,
the samples were cryoprotected with 10% sucrose, frozen and
sectioned at 5 mm. The polyclonal (rabbit) antibody against
neurexin-I was kindly provided by Dr Wei Xie, Department of
Genetics and Developmental Biology, Genetics Research Center,
Southeast University Medical School, China. Monoclonal antibody
against Drosophila synaptic-vesicle associated protein synapsin I
(SYNORF1) was purchased from the Developmental Studies
Hybridoma Bank (DSHB), USA. For immuno-staining, sections
were permeablized with 0.2% Triton X100 in 0.1 M PBS, pre-
incubated with 2% normal goat serum for one hour and incubated
with either SynOrf-1 (dilution 1:50) or neurexin-I antibody (dilution
1:20) overnight at 4uC. Multiple rinsing in 0.1 MPBS was followed
by incubation with secondary antibodies diluted at 1:300 for one
hour at room temperature. Alexa-546-conjugated anti-rabbit
antibody (Molecular Probes, Invitrogen) was applied in the case of
Neurexin-1, and Alexa-488-conjugated anti-mouse antibody (Mo-
lecular Probes,Invitrogen)was applied inthe case of SynOrf-1. After
thorough rinsing, sections were mounted in 50% glycerol. For
neurexin-I and SynOrf-1 double labelling; sections were incubated
in a mixture of primary and secondary antibodies mentioned above.
In control experiments, primary antibodies were omitted. Digital
images were taken in a Zeiss Axioscop fluorescent microscope using
SPOT digital camera with SPOT RT software. The images were
optimized by adjusting brightness/contrast levels using Adobe
Illustrator software. Six brains were assayed.
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